
Traklot 500mg Injection
Marketer
Kontest Chemicals Ltd
Salt Composition
Tranexamic Acid (500mg)
Overview Traklot 500mg Injection
Hemostop 500mg Injection effectively manages hemorrhaging. Its application encompasses various scenarios, including dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and procedures involving the oral cavity, prostate, or bladder. Hemostop 500mg Injection functions as an antifibrinolytic agent, inhibiting clot dissolution and thus controlling bleeding. Administration requires the guidance of a healthcare provider. Individuals with known allergies to this medication should avoid its use. Frequently reported adverse effects comprise injection site reactions, fatigue, musculoskeletal discomfort, and nasal stuffiness. Prior cardiac surgery or kidney impairment necessitates disclosure to your physician. This injection is deemed safe for pregnant and lactating women, and for those with liver conditions.
Uses of Traklot 500mg Injection
Managing Hemorrhage
Major Benefits of Traklot 500mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Traklot 500mg Injection:
- Joint pain
- Headache
- Back pain
- Vomiting
- Nausea
- Abdominal pain
- Diarrhea
- Muscle cramp
- Anemia (low number of red blood cells)
- Lightheadedness
How to use Traklot 500mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Traklot 500mg Injection works:
Hemostatic agent Traklot 500mg Injection inhibits fibrinolysis, thus stabilizing blood clots and mitigating excessive hemorrhage associated with menstruation or post-surgical complications.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Traklot 500mg Injection and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the administration of Traklot 500mg Injection to pregnant individuals is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Administration of Traklot 500mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Traklot 500mg Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Traklot 500mg Injection to individuals with impaired renal function. Dosage modification of Traklot 500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Traklot 500mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is advised.
What if you forget to take Traklot 500mg Injection :
Omit a Traklot 500mg Injection dose? Seek your physician's advice.
Facts to Know About Traklot 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
